TOKYO -- South Korean drugmaker Celltrion has recorded positive preclinical results for its coronavirus treatment, the company announced on Monday.
Pharmaceuticals
Celltrion's coronavirus drug shows promise in animal tests
South Korean pharmaceutical records 100-fold viral load reduction
The company said the pre-clinical study was conducted in an animal model in collaboration with one of the Korean National Universities, Chungbuk National University College of Medicine. (Photo courtesy of Celltrion)
Read Next
Latest on Pharmaceuticals
